Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Pediatr Transplant. 2010 Jan 4;14(4):534–539. doi: 10.1111/j.1399-3046.2009.01268.x

Table 4.

Multivariable survival models for time to BOS and time to death with acute rejection episodes as time-dependent risk factors

BOS: 383 subjects, 58 events Death/Re-tx: 383 subjects, 51 events BOS/Death/Re-tx: 383 subjects, 106 events
Risk factor vs. no rejection Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value Hazard ratio (95% CI) P-value
Risk following first A1 1.7 (0.64, 4.8) 0.28 0.82 (0.36, 1.9) 0.65 1.10 (0.57, 2.1) 0.78
Risk following first A2 2.4 (1.1, 5.1) 0.022 0.49 (0.21, 1.2) 0.11 1.09 (0.62, 1.9) 0.76
Risk following second A1 1.1 (0.25, 5.2) 0.86 1.10 (0.32, 3.7) 0.88 1.1 (0.43, 2.9) 0.80
Risk following second A2 4.1 (1.9, 9.0) <0.001 0.74 (0.30, 1.9) 0.52 1.8 (1.01, 3.2) 0.046
Risk following second rejection, mixed rejection types 4.4 (2.2, 9.1) <0.001 2.0 (1.00, 4.1) 0.048 2.7 (1.6, 4.6) <0.001

BOS, bronchiolitis obliterans syndrome; Re-tx, re-transplantation